Company

Insu Therapeutics Inc.

Follow Open structure map Ask about this Research this company

Description

Headquarters: CA

Structure of Insu Therapeutics Inc.

Insu Therapeutics Inc.

Company

7 connections

OwnershipInvestment and holdings1 of 2

UpstreamSupply and dependency1 of 2

ConstraintsRegulation and exposure

OwnProducts and technology

Relationship began2026Unsorted nodes

Insu Therapeutics Inc.Company · 7 connections

Layer 1

UpstreamSupply and dependency1

OwnershipInvestment and holdings1

OwnProducts and technology4

ConstraintsRegulation and exposure1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

Hydreight Technologies Inc.invests in →Insu Therapeutics Inc.
Company · Hydreight Technologies Inc.Evidence 2
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  Hydreight completed a C$300,000 investment in Insu
  View source
- CompanyPR Newswire news releases2026-10-08 19:30
  Hydreight Technologies Inc. has also invested in Insu
  View source
Insu Therapeutics Inc.uses →buccal delivery technology
Technology · buccal delivery technologyEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  exclusive U.S. rights to distribute peptide therapeutics utilizing Insu's buccal delivery technology
  View source
Insu Therapeutics Inc.located in →Vancouver
Geography · VancouverEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  Insu Therapeutics Inc. is a Vancouver-based biotechnology company and UBC spin-off developing needle-free buccal formulations for peptide medicines.
  View source
Insu Therapeutics Inc.part of →biotechnology
Industry · biotechnologyEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  Insu Therapeutics Inc. is a Vancouver-based biotechnology company and UBC spin-off developing needle-free buccal formulations for peptide medicines.
  View source
InsuTabpart of →Insu Therapeutics Inc.
Product · InsuTabEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  Its initial programs are InsuTab, a buccal insulin formulation, and BuccaGLP, a buccal semaglutide formulation.
  View source
BuccaGLPpart of →Insu Therapeutics Inc.
Product · BuccaGLPEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  Its initial programs are InsuTab, a buccal insulin formulation, and BuccaGLP, a buccal semaglutide formulation.
  View source
Hydreight Technologies Inc.invests in →Insu Therapeutics Inc.
Company · Hydreight Technologies Inc.Evidence 2
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  Hydreight completed a C$300,000 investment in Insu
  View source
- CompanyPR Newswire news releases2026-10-08 19:30
  Hydreight Technologies Inc. has also invested in Insu
  View source
Insu Therapeutics Inc.uses →Buccal peptide-delivery technology
Technology · Buccal peptide-delivery technologyEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-08 19:30
  a patent application covering its buccal peptide-delivery technology
  View source

Showing 1 to 8 of 10

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

part ofInsuTab™

InsuTab™, Insu's investigational buccal insulin formulation